AntiTum Cancer Research Results
AntiTum, AntiTumor: Click to Expand ⟱
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
AntiTum↑,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
*BioAv↑, AntiTum↑, eff↑, TumCG↓, angioG↓, TumMeta↓, eff↑, *toxicity↓, other↝,
*GutMicro↑, Apoptosis↑, BAX↑, Bcl-2↓, *Inflam↓, AntiTum↑,
TOP1↓, AntiTum↑,
ER Stress↑, ROS↑, AntiTum↑, GSH↓, Ferroptosis↑, selectivity↑, GSH/GSSG↓, *ROS∅, eff↑,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AntiTum↑, TumCI↓, Apoptosis↑, ROS↑, Cyt‑c↑, Akt↓, mTOR↓, TumCG↓, TumMeta↓,
| - |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AntiTum↑, OS↑, QoL↑, TumVol↓, radioP↑, Dose↑, Dose↝, eff↑,
*antiOx↑, *Inflam↓, AntiTum↑, *BioAv↓, *Half-Life↓, *BioAv↝, *BioAv↓,
AntiTum↑, Risk↓, ChemoSen↑,
AntiTum↑, TumCP↓, tumCV↓, TumCCA↑, Mcl-1↓, RAS↓, e-Raf↓, VEGF↓, AntiAg↑, MMP2↓, MMP9↓, TIMP2↑, TIMP1↑, p38↓, Wnt↓, β-catenin/ZEB1↑, Casp↑, P53↑, BAX↑, COX2↓, GLO-I↓, CYP1A1↑, lipid-P↓, p‑Akt↓, p‑mTOR↓, VCAM-1↓, P-gp↓, survivin↓, Bcl-2↓, ROS↑, ROS↑, MAPK↑, STAT3↓, chemoP↑,
toxicity∅, AntiTum↑, MAPK↑, ERK↓, ChemoSen↑, ChemoSen↑, RadioS↑,
AntiTum↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, Bcl-xL↓, P53↑, NAF1↓, NRF2↑, ROS↑, Apoptosis↑, HDAC↓, TumCCA↑, TumAuto↑, angioG↓, iNOS↓,
*ROS↓, *selenoP↑, *antiOx↑, *Inflam↓, *Risk↓, *toxicity↓, AntiTum↑, Dose↝,
AntiTum↑, HDAC↓,
| - |
Study, |
HCC, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AntiTum↑, GTPBP4↓, PKM2↓, lactateProd↓, GlucoseCon↓, Glycolysis↓, E-cadherin↑, TumCG↓,
| - |
in-vitro, |
ESCC, |
Eca109 |
|
|
|
- |
in-vitro, |
ESCC, |
EC9706 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
tumCV↓, TumCCA↑, Apoptosis↑, EGFR↓, PI3K↓, Hif1a↓, PKM2↓, cycD1/CCND1↓, AntiTum↑,
Showing Research Papers: 1 to 17 of 17
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 17
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
CYP1A1↑, 1, Ferroptosis↑, 1, GSH↓, 1, GSH/GSSG↓, 1, lipid-P↓, 1, NAF1↓, 1, NRF2↑, 1, PARK2↑, 1, ROS↑, 6,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, PINK1↑, 1, e-Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, GLO-I↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, PKM2↓, 2,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 4, BAX↑, 4, Bcl-2↓, 4, Bcl-xL↓, 2, Casp↑, 1, Casp3↑, 1, cl‑Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, Ferroptosis↑, 1, iNOS↓, 1, MAPK↑, 2, Mcl-1↓, 1, p38↓, 1, survivin↓, 1,
Transcription & Epigenetics ⓘ
other↝, 1, tumCV↓, 2,
Protein Folding & ER Stress ⓘ
ER Stress↑, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 2,
DNA Damage & Repair ⓘ
P53↑, 2, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, ERK↓, 1, GTPBP4↓, 1, HDAC↓, 3, mTOR↓, 1, mTOR↑, 1, p‑mTOR↓, 1, PI3K↓, 1, RAS↓, 1, STAT3↓, 1, TOP1↓, 1, TumCG↓, 4, Wnt↓, 1,
Migration ⓘ
AntiAg↑, 1, E-cadherin↑, 2, miR-139-5p↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, Snail↓, 1, TIMP1↑, 1, TIMP2↑, 1, TumCI?, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 3, VCAM-1↓, 1, Vim↓, 1, β-catenin/ZEB1↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 2, EGFR↓, 1, Hif1a↓, 1, VEGF↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 3, Dose↑, 1, Dose↝, 2, eff↓, 1, eff↑, 4, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 17, chemoP↑, 1, OS↑, 1, QoL↑, 1, radioP↑, 1, Risk↓, 1, toxicity∅, 1, TumVol↓, 1,
Total Targets: 97
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, ROS↓, 1, ROS∅, 1, selenoP↑, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 3,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 1, BioAv↝, 1, Half-Life↓, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1,
Functional Outcomes ⓘ
Risk↓, 1, toxicity↓, 2,
Total Targets: 12
Scientific Paper Hit Count for: AntiTum, AntiTumor
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:913 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page